{"id":"https://openalex.org/W2463742437","doi":"https://doi.org/10.1016/j.atherosclerosis.2016.07.001","title":"Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan","display_name":"Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan","publication_year":2016,"publication_date":"2016-07-04","ids":{"openalex":"https://openalex.org/W2463742437","doi":"https://doi.org/10.1016/j.atherosclerosis.2016.07.001","mag":"2463742437","pmid":"https://pubmed.ncbi.nlm.nih.gov/27419905"},"language":"en","primary_location":{"id":"doi:10.1016/j.atherosclerosis.2016.07.001","doi":"https://doi.org/10.1016/j.atherosclerosis.2016.07.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.atherosclerosis.2016.07.001","pdf_url":null,"source":{"id":"https://openalex.org/S206830620","display_name":"Atherosclerosis","issn_l":"0021-9150","issn":["0021-9150","1879-1484"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.atherosclerosis.2016.07.001","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102165046","display_name":"Tamio Teramoto","orcid":"https://orcid.org/0000-0002-8121-7484","observed_orcids":["https://orcid.org/0000-0002-8121-7484"]},"institutions":[{"id":"https://openalex.org/I87531838","display_name":"Teikyo University","ror":"https://ror.org/01gaw2478","country_code":"JP","type":"education","lineage":["https://openalex.org/I87531838"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tamio Teramoto","raw_affiliation_strings":["Teikyo Academic Research Center, 2-11-1, Kaga, Itabashi-ku, Tokyo 173-8605, Japan. Electronic address: ttera@med.teikyo-u.ac.jp","Teikyo Academic Research Center, 2-11-1, Kaga, Itabashi-ku, Tokyo 173-8605, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teikyo Academic Research Center, 2-11-1, Kaga, Itabashi-ku, Tokyo 173-8605, Japan. Electronic address: ttera@med.teikyo-u.ac.jp","institution_ids":["https://openalex.org/I87531838"]},{"raw_affiliation_string":"Teikyo Academic Research Center, 2-11-1, Kaga, Itabashi-ku, Tokyo 173-8605, Japan","institution_ids":["https://openalex.org/I87531838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110824972","display_name":"Kiyoko Uno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141885","display_name":"Sanofi (Japan)","ror":"https://ror.org/040h02z76","country_code":"JP","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210141885"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kiyoko Uno","raw_affiliation_strings":["Sanofi, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Tokyo, Japan","institution_ids":["https://openalex.org/I4210141885"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025780620","display_name":"Izuru Miyoshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141885","display_name":"Sanofi (Japan)","ror":"https://ror.org/040h02z76","country_code":"JP","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210141885"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Izuru Miyoshi","raw_affiliation_strings":["Sanofi, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Tokyo, Japan","institution_ids":["https://openalex.org/I4210141885"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075397090","display_name":"Irfan Khan","orcid":"https://orcid.org/0000-0002-9832-0904","observed_orcids":["https://orcid.org/0000-0002-9832-0904"]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irfan Khan","raw_affiliation_strings":["Sanofi, Bridgewater, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Bridgewater, NJ, USA","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021126466","display_name":"Katherine Gorcyca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Gorcyca","raw_affiliation_strings":["Sanofi, Bridgewater, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Bridgewater, NJ, USA","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002862446","display_name":"Robert J. Sanchez","orcid":"https://orcid.org/0000-0002-2998-3202","observed_orcids":["https://orcid.org/0000-0002-2998-3202"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Sanchez","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043837865","display_name":"Shigeto Yoshida","orcid":"https://orcid.org/0000-0001-5056-6473","observed_orcids":["https://orcid.org/0000-0001-5056-6473"]},"institutions":[{"id":"https://openalex.org/I4210143791","display_name":"Institute for Molecular Science","ror":"https://ror.org/04wqh5h97","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1319490839","https://openalex.org/I199525922","https://openalex.org/I4210143791"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeto Yoshida","raw_affiliation_strings":["IMS Japan K.K., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Japan K.K., Tokyo, Japan","institution_ids":["https://openalex.org/I4210143791"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kazuhiro Mawatari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143791","display_name":"Institute for Molecular Science","ror":"https://ror.org/04wqh5h97","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1319490839","https://openalex.org/I199525922","https://openalex.org/I4210143791"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhiro Mawatari","raw_affiliation_strings":["IMS Japan K.K., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Japan K.K., Tokyo, Japan","institution_ids":["https://openalex.org/I4210143791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001096322","display_name":"Tomoya Masaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143791","display_name":"Institute for Molecular Science","ror":"https://ror.org/04wqh5h97","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1319490839","https://openalex.org/I199525922","https://openalex.org/I4210143791"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoya Masaki","raw_affiliation_strings":["IMS Japan K.K., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Japan K.K., Tokyo, Japan","institution_ids":["https://openalex.org/I4210143791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076061467","display_name":"Hidenori Arai","orcid":"https://orcid.org/0000-0002-9000-6849","observed_orcids":["https://orcid.org/0000-0002-9000-6849","https://orcid.org/0000-0001-6747-8680"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hidenori Arai","raw_affiliation_strings":["Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I22299242"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103268361","display_name":"Shizuya Yamashita","orcid":"https://orcid.org/0000-0002-8413-5468","observed_orcids":["https://orcid.org/0000-0002-8413-5468"]},"institutions":[{"id":"https://openalex.org/I4405254471","display_name":"Rinku General Medical Center","ror":"https://ror.org/01v60bs72","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405254471"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shizuya Yamashita","raw_affiliation_strings":["Rinku General Medical Center, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rinku General Medical Center, Osaka, Japan","institution_ids":["https://openalex.org/I4405254471"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5102165046"],"corresponding_institution_ids":["https://openalex.org/I87531838"],"apc_list":{"value":4020,"currency":"USD","value_usd":4020},"apc_paid":{"value":4020,"currency":"USD","value_usd":4020},"fwci":8.7751,"has_fulltext":false,"cited_by_count":72,"citation_normalized_percentile":{"value":0.98452506,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"251","issue":null,"first_page":"248","last_page":"254"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9049999713897705},{"id":"https://openalex.org/keywords/ldl-c-target-attainment","display_name":"LDL-C goal attainment","score":0.8669999837875366},{"id":"https://openalex.org/keywords/lipid-modifying-therapy","display_name":"lipid therapy","score":0.9490000009536743},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8389999866485596},{"id":"https://openalex.org/keywords/high-cardiovascular-risk-patients","display_name":"high cardiovascular risk patients","score":0.7350000143051147},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.8339999914169312},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.9959999918937683},{"id":"https://openalex.org/keywords/peripheral-arterial-disease","display_name":"peripheral arterial disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.984000027179718},{"id":"https://openalex.org/keywords/japan","display_name":"Japan","score":0.4860000014305115}],"concepts":[{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5839132070541382},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.559458315372467},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4712912142276764},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.396093487739563},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30465933680534363}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.atherosclerosis.2016.07.001","doi":"https://doi.org/10.1016/j.atherosclerosis.2016.07.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.atherosclerosis.2016.07.001","pdf_url":null,"source":{"id":"https://openalex.org/S206830620","display_name":"Atherosclerosis","issn_l":"0021-9150","issn":["0021-9150","1879-1484"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis","raw_type":"journal-article"},{"id":"pmid:27419905","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27419905","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:00953:0006830302","doi":null,"is_oa":true,"landing_page_url":"https://pure.teikyo.jp/en/publications/41cc098e-49f9-46f6-8456-d074f0db7ef2","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Atherosclerosis","raw_type":"journal article"}],"best_oa_location":{"id":"doi:10.1016/j.atherosclerosis.2016.07.001","doi":"https://doi.org/10.1016/j.atherosclerosis.2016.07.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.atherosclerosis.2016.07.001","pdf_url":null,"source":{"id":"https://openalex.org/S206830620","display_name":"Atherosclerosis","issn_l":"0021-9150","issn":["0021-9150","1879-1484"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320320344","display_name":"European Society of Cardiology","ror":"https://ror.org/02ahe3232"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W52699624","https://openalex.org/W1482509885","https://openalex.org/W1520609538","https://openalex.org/W1965007842","https://openalex.org/W1970853900","https://openalex.org/W1972661406","https://openalex.org/W1972966413","https://openalex.org/W1979755481","https://openalex.org/W1983437747","https://openalex.org/W1985458650","https://openalex.org/W2006914954","https://openalex.org/W2007347036","https://openalex.org/W2019071303","https://openalex.org/W2033024867","https://openalex.org/W2034277718","https://openalex.org/W2047955620","https://openalex.org/W2052094004","https://openalex.org/W2054605244","https://openalex.org/W2070287724","https://openalex.org/W2082643036","https://openalex.org/W2097092357","https://openalex.org/W2110171695","https://openalex.org/W2126678006","https://openalex.org/W2132064529","https://openalex.org/W2133247967","https://openalex.org/W2134306662","https://openalex.org/W2142164422","https://openalex.org/W2154836846","https://openalex.org/W2155121555","https://openalex.org/W2162136177","https://openalex.org/W2164089346","https://openalex.org/W2316863796","https://openalex.org/W2319050272","https://openalex.org/W2330820172","https://openalex.org/W2331774389","https://openalex.org/W4211109054","https://openalex.org/W4239279466","https://openalex.org/W4241996320","https://openalex.org/W4242832610","https://openalex.org/W4251851417","https://openalex.org/W6906490681"],"related_works":["https://openalex.org/W2769252393","https://openalex.org/W2999264936","https://openalex.org/W4327640186","https://openalex.org/W2602580500","https://openalex.org/W2761827590","https://openalex.org/W3037055026","https://openalex.org/W2999590525","https://openalex.org/W2791926717","https://openalex.org/W2765225445","https://openalex.org/W2796240024"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"AIMS:":[2],"Low-density":[3],"lipoprotein":[4],"cholesterol":[5],"(LDL-C)":[6],"is":[7],"a":[8,59,108,205,211],"key":[9],"modifiable":[10],"risk":[11,41,62,111,151,208],"factor":[12],"in":[13,37,58,64,80,90,95,104,140,210,215,245],"the":[14,22,69,84,105,141,154,160,241],"development":[15],"of":[16,49,99,147,159,176,198,224,243],"cardiovascular":[17],"(CV)":[18],"disease.":[19],"In":[20,204,231],"2012,":[21],"Japan":[23],"Atherosclerosis":[24],"Society":[25],"(JAS)":[26],"issued":[27],"guidelines":[28],"recommending":[29],"statins":[30,225,244],"as":[31],"first-line":[32],"pharmacotherapy":[33],"for":[34,42,181,184,189],"lowering":[35],"LDL-C":[36,51,93,131,138,165,177,219,250],"patients":[38,152,246],"at":[39],"high":[40,60,109,149,206],"CV":[43,61,110,150,207],"events.":[44],"This":[45],"study":[46],"assessed":[47,135],"achievement":[48],"recommended":[50,164,218],"goals":[52,178],"and":[53,107,186,193,222,226],"lipid-modifying":[54],"therapy":[55],"(LMT)":[56],"use":[57,197],"population":[63,209],"Japan.":[65],"METHODS:":[66],"Patients":[67],"from":[68],"Medical":[70],"Data":[71],"Vision":[72],"(MDV)":[73],"database,":[74],"an":[75],"electronic":[76],"hospital-based":[77],"claims":[78],"database":[79],"Japan,":[81,216],"who":[82],"met":[83,153],"following":[85],"inclusion":[86,155],"criteria":[87],"were":[88],"included":[89],"this":[91],"study:":[92],"measurement":[94],"2013;":[96],"\u226520":[97],"years":[98,102],"age;":[100],"\u22652":[101],"representation":[103],"database;":[106],"condition":[112],"(recent":[113],"acute":[114],"coronary":[115,119],"syndrome":[116],"(ACS),":[117],"other":[118,227],"heart":[120],"disease":[121,127],"(CHD),":[122],"ischemic":[123,190],"stroke,":[124,191],"peripheral":[125],"arterial":[126],"(PAD)":[128],"or":[129],"diabetes).":[130],"goal":[132,220],"attainment":[133,221],"was":[134,179,201,229],"based":[136],"on":[137],"targets":[139],"JAS":[142],"guidelines.":[143],"RESULTS:":[144],"A":[145],"total":[146],"33,325":[148],"criteria.":[156],"Overall,":[157],"68%":[158,180],"cohort":[161],"achieved":[162],"guideline":[163,217],"targets,":[166],"with":[167,173,247],"only":[168],"42%":[169],"receiving":[170],"current":[171],"treatment":[172],"statins.":[174],"Attainment":[175],"ACS,":[182],"55%":[183],"CHD,":[185],"80%":[187],"each":[188],"PAD,":[192],"diabetes":[194],"patients.":[195],"Concomitant":[196],"non-statin":[199],"LMTs":[200],"low.":[202,230],"CONCLUSIONS:":[203],"routine":[212],"care":[213],"setting":[214],"utilization":[223],"LMT":[228],"addition,":[232],"physicians":[233],"appeared":[234],"to":[235,239],"be":[236],"more":[237],"likely":[238],"consider":[240],"initiation":[242],"higher":[248],"baseline":[249],"levels.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-07-22T00:00:00"}